Urine Albumin-to-Creatinine Ratio Test

The urine albumin-to-creatinine ratio, or UACR, measures the amount of albumin, a protein normally found in the blood, that is being lost into the urine. Under healthy conditions, the kidneys act as filters that keep albumin in the bloodstream. When the kidney’s filtering units (the glomeruli) become damaged, small amounts of albumin begin to leak into the urine. Detecting this leak early is crucial because it often signals the beginning of kidney disease and can also reflect broader blood vessel injury.

Because urine concentration can vary depending on how hydrated you are, UACR corrects for this by comparing albumin to creatinine, a stable breakdown product of muscle that is excreted at a steady rate. This makes UACR much more reliable than simply measuring total urine protein. A simple “spot” urine test is usually enough, sparing patients the need for inconvenient 24-hour collections.

Even small increases in UACR, below the traditional “microalbuminuria” cutoff of 30 mg/g, are now recognized as important. These lower levels can still predict future risks such as high blood pressure, stroke, heart attack, and earlier death. In people with diabetes or hypertension, UACR is especially valuable, since elevated levels forecast faster progression to chronic kidney disease. Importantly, UACR reflects more than just kidney function—it also points to vascular health more broadly, since albumin leakage often indicates damage to the blood vessel lining (the endothelium).

Higher UACR levels can be seen in conditions such as diabetes, hypertension, and heart failure. They may also rise temporarily after vigorous exercise, infections, or during pregnancy complications such as pre-eclampsia. For this reason, repeated measurements are often recommended before diagnosing kidney disease. On the other hand, a very low UACR is usually considered reassuring, though it does not rule out all forms of kidney or vascular injury.

Clinicians now use UACR alongside estimated glomerular filtration rate (eGFR) to classify chronic kidney disease. Together, these two measures provide a powerful picture of kidney and cardiovascular risk. In fact, UACR often detects early damage long before eGFR starts to decline, giving patients and doctors a critical window to intervene with lifestyle changes and medications.